Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma

被引：0
|
作者：
Tamura, A. [1 ]
Yoshida, M. [2 ]
Yamamoto, N. [1 ]
Nakamura, S. [1 ]
Fujiwara, T. [1 ]
Tahara, T. [1 ]
Saito, A. [1 ]
Kozaki, A. [1 ]
Kishimoto, K. [1 ]
Ishida, T. [1 ]
Hasegawa, D. [1 ]
Kosaka, Y. [1 ]
机构：
[1] Kobe Childrens Hosp, Hematol & Oncol, Kobe, Hyogo, Japan
[2] Kobe Childrens Hosp, Dept Diagnost Pathol, Kobe, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-538
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
    Spurny, Christian
    Kailayangiri, Sareetha
    Jamitzky, Silke
    Altvater, Bianca
    Wardelmann, Eva
    Dirksen, Uta
    Hardes, Jendrik
    Hartmann, Wolfgang
    Rossig, Claudia
    PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
  • [2] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [3] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [4] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [5] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [6] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [7] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [8] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [9] Clinical impact of programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1), and CD8 expression in pancreatic cancer
    Shim, Hyun-Jeong
    Hwang, Jun-Eul
    Jung, Sook-In
    Lee, Kyung-Hwa
    Chung, Ik-Joo
    Cho, Sang-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Programmed Cell Death 1 Ligand 1 (PD-L1) Expression in Thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nishi, Tatsuya
    Matsumoto, Ryouichi
    Hashiguchi, Toshihiro
    Murakami, Daigo
    Kashihara, Masaki
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S503 - S503
12345